Teachers Advisors’s Viking Therapeutics VKTX Stock Holding History

Teachers Advisors’s Portfolio VKTX Stock Details VKTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$1.51M	Buy	152,076 +9,891	+7%	+$82.8K	﹤0.01%	2113
2018 Q4	$1.09M	Buy	142,185 +14,795	+12%	+$177K	﹤0.01%	2148
2018 Q3	$2.22M	Buy	127,390 +43,960	+53%	+$523K	﹤0.01%	1923
2018 Q2	$792K	Buy	+83,430	New	+$555K	﹤0.01%	2450

Other funds holding VKTX

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

Fiera Capital (Canada) Montreal, Quebec, Canada $29.2B AUM 20.16% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Teachers Advisors's VKTX Position: Q1 2019 in Review

Teachers Advisors increased its Viking Therapeutics (VKTX) stake by 7% in Q1 2019, buying an estimated $82.8K and bringing the position to 152,076 shares worth $1.51M. The position accounts for ﹤0.01% of the portfolio, ranked #2113.

Teachers Advisors first reported a position in VKTX in Q2 2018 and has held it in 4 quarters since. The position peaked at $2.22M in Q3 2018. 164 funds tracked by Wall St. Rank hold VKTX as of Q1 2019.

Teachers Advisors held 152,076 shares of Viking Therapeutics worth $1.51M as of Q1 2019.
Teachers Advisors bought 9,891 Viking Therapeutics shares in Q1 2019, an estimated $82.8K.
Viking Therapeutics made up ﹤0.01% of Teachers Advisors's portfolio in Q1 2019, its #2113 holding.
Teachers Advisors first reported a position in Viking Therapeutics in Q2 2018 and has held it in 4 quarters since.
Teachers Advisors's Viking Therapeutics position peaked at $2.22M in Q3 2018.
164 funds tracked by Wall St. Rank held Viking Therapeutics as of Q1 2019.

Based on Teachers Advisors's 13F filing for Q1 2019, filed 14 May 2019.